483 related articles for article (PubMed ID: 31655904)
1. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
[TBL] [Abstract][Full Text] [Related]
2. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
Morsy GH
J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA
Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605
[TBL] [Abstract][Full Text] [Related]
4. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.
Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS
Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
8. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
10. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
Botros SS; Hammam O; Mahmoud M; Bergquist R
APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
[TBL] [Abstract][Full Text] [Related]
11. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
[TBL] [Abstract][Full Text] [Related]
12. Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment.
Sharaf El-Deen SA; Brakat RM; Mohamed ASED
Exp Parasitol; 2017 Jul; 178():51-59. PubMed ID: 28552793
[TBL] [Abstract][Full Text] [Related]
13. The potent effect of silymarin combination with Praziquantel or mirazid for Schistosoma mansoni treatment in infected male swiss albino mice.
El-Nagar DM; Al Olayan EM; Aloufi AS; Khatab AR
Trop Biomed; 2021 Mar; 38(1):22-27. PubMed ID: 33797519
[TBL] [Abstract][Full Text] [Related]
14. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
[TBL] [Abstract][Full Text] [Related]
15. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
[TBL] [Abstract][Full Text] [Related]
16. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
[TBL] [Abstract][Full Text] [Related]
17. Parasitological and Biochemical Efficacy of the Active Ingredients of
Abu Almaaty AH; Rashed HAE; Soliman MFM; Fayad E; Althobaiti F; El-Shenawy NS
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361695
[TBL] [Abstract][Full Text] [Related]
18. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
19. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
20. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]